Bruker's Mass-Spec Sales Grow in Double Digits in Q2; Total Revenue Declines 18.9 Percent | GenomeWeb

This story originally ran on July 29.

Bruker on Wednesday said that its life-science mass spectrometers saw double-digit growth in the second quarter even though total revenue fell 18.9 percent year over year.

For the three months ended June 30, Bruker said total receipts shrank to $252.5 million from $311.5 million a year ago. Excluding the effects of foreign currency, revenues for the quarter fell 11.1 percent year over year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.